NORTHAMPTON, MA / ACCESS Newswire / March 25, 2025 / HIV infection and lung cancer have little in common from a disease ...

It’s been a long minute since we’ve spent time in the hellscape of Gilead with The Handmaid’s Tale. Season five wrapped up in ...

The head of the U.N. AIDS agency says the sudden loss of American money has been “devastating” for efforts to stop HIV and ...

The Health and Human Services Department is considering cuts to HIV prevention funding, according to The Wall Street Journal.

Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Gilead Sciences (GILD – Research Report) today and set a price target of $90.00.

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Ahead of The Handmaid’s Tale Season 6, find out why this “brutal” scene involving Fred Waterford and Serena Joy was scrapped.

So, assuming 2% growth, Gilead is slightly undervalued. In fact, Gilead appears valued for 0% growth. Actually, this may be a ...

The sixth and final season of the award-winning Hulu drama will be a “love letter” to fans who’ve stuck with it through five ...

Elisabeth Moss is leading a rebellion in the final season The Handmaid's Tale, which arrives on Hulu April 8. The streamer ...